Loading...
Please wait, while we are loading the content...
Similar Documents
Current Clinical Trials Protocols and the Global Effort for Immunization against SARS-CoV-2
| Content Provider | MDPI |
|---|---|
| Author | Rego, Gabriel Nucci, Mariana Alves, Arielly Oliveira, Fernando Marti, Luciana Nucci, Leopoldo Mamani, Javier Gamarra, Lionel |
| Copyright Year | 2020 |
| Description | Coronavirus disease 2019 (COVID-19) is the biggest health challenge of the 21st century, affecting millions of people globally. The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has ignited an unprecedented effort from the scientific community in the development of new vaccines on different platforms due to the absence of a broad and effective treatment for COVID-19 or prevention strategy for SARS-CoV-2 dissemination. Based on 50 current studies selected from the main clinical trial databases, this systematic review summarizes the global race for vaccine development against COVID-19. For each study, the main intervention characteristics, the design used, and the local or global center partnerships created are highlighted. Most vaccine developments have taken place in Asia, using a viral vector method. Two purified inactivated SARS-CoV-2 vaccine candidates, an mRNA-based vaccine mRNA1273, and the chimpanzee adenoviral vaccine ChAdOx1 are currently in phase III clinical trials in the respective countries Brazil, the United Arab Emirates, the USA, and the United Kingdom. These vaccines are being developed based on a quickly formed network of collaboration. |
| Starting Page | 474 |
| e-ISSN | 2076393X |
| DOI | 10.3390/vaccines8030474 |
| Journal | Vaccines |
| Issue Number | 3 |
| Volume Number | 8 |
| Language | English |
| Publisher | MDPI |
| Publisher Date | 2020-08-25 |
| Access Restriction | Open |
| Subject Keyword | Vaccines Infectious Diseases Covid-19 Sars-cov-2 Immunization Vaccine Research and Development (r& |
| Content Type | Text |
| Resource Type | Article |
